MYLAN Stock Quote

$38.33 arrow  Change: -0.27 %Chge: -0.69% Vol: 245,552
End Of Day Prices
High: 38.81 | Low: 38.13 | Open: 38.81 | Close: 38.33
52 Wk High: 47.67 | 52 Wk Low: 29.525 | Todays Pivot: 38.42
Sector: Healthcare and Pharmaceuticals add stock to watch list

MYL Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Tenet Healthcare 6.49 green arrow 29,230,500
Medco Health Solutions 47.93 red arrow 279,776
Patterson Companies 42.24 red arrow 35,126
Davita 64.41 green arrow 119,882
Edwards Lifesciences 76.8 green arrow 71,525
Varian Med Sys 66.12 green arrow 101,292
Aetna 125.95 green arrow 56,686
Mednax 63.78  arrow 437,800

Above is a small selection of related companies to Mylan which compete alongside MYL within the Healthcare and Pharmaceuticals sector. To see more related companies to MYL, view our stock market today information page.

Online News For Mylan

Summer boys lacrosse sponsored MYL

Summer boys lacrosse for boys pre K-thru-8 is being offered by Milford Youth Lacrosse on Wednesdays June 27 to Aug 1 from 6 to 7:15 p.m. at Orange Avenue turf field next to the Woodruff YMCA. Register at Equipment needed: stick ...

Mylan NV Valuation – June 2018 $MYL

Downloadable PDF Version of the Valuation - For easy printing and your own record-keeping. Cancellation and Refunds: If you are unhappy with your subscription for any reason, please send an email to to cancel. If immediate ...

First Week of MYL August 17th Options Trading

Investors in Mylan NV (Symbol: MYL) saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MYL options chain for the new August 17th contracts and identified one ...

Mylan (MYL) to Get CRL Again for Generic Advair from FDA

Shares of Mylan N.V. (MYL - Free Report) are down after the company announced that the FDA will not approve its Abbreviated New Drug Application for the generic version of GlaxoSmithKline’s (GSK - Free Report) asthma drug, Advair Diskus, yet again.

Mylan (MYL) Announces Launch of Generic Angiomax Injection

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Bivalirudin for Injection, 250 mg single-dose vial, a ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Mylan quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for MYL to choose from. Visit here to build your stock quote widget »